Publication: Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
dc.contributor.author | Casali, P. G. | |
dc.contributor.author | Abecassis, N. | |
dc.contributor.author | Bauer, S. | |
dc.contributor.author | Biagini, R. | |
dc.contributor.author | Bielack, S. | |
dc.contributor.author | Bonvalot, S. | |
dc.contributor.author | Boukovinas, I. | |
dc.contributor.author | Bovee, J. V. M. G. | |
dc.contributor.author | Brodowicz, T. | |
dc.contributor.author | Broto, J. M. | |
dc.contributor.author | Buonadonna, A. | |
dc.contributor.author | De Alava, E. | |
dc.contributor.author | Dei Tos, A. P. | |
dc.contributor.author | Del Muro, X. G. | |
dc.contributor.author | Dileo, P. | |
dc.contributor.author | Eriksson, M. | |
dc.contributor.author | Fedenko, A. | |
dc.contributor.author | Ferraresi, V. | |
dc.contributor.author | Ferrari, A. | |
dc.contributor.author | Ferrari, S. | |
dc.contributor.author | Frezza, A. M. | |
dc.contributor.author | Gasperoni, S. | |
dc.contributor.author | Gelderblom, H. | |
dc.contributor.author | Gil, T. | |
dc.contributor.author | Grignani, G. | |
dc.contributor.author | Gronchi, A. | |
dc.contributor.author | Haas, R. L. | |
dc.contributor.author | Hannu, A. | |
dc.contributor.author | Hassan, B. | |
dc.contributor.author | Hohenberger, P. | |
dc.contributor.author | Issels, R. | |
dc.contributor.author | Joensuu, H. | |
dc.contributor.author | Jones, R. L. | |
dc.contributor.author | Judson, I. | |
dc.contributor.author | Jutte, P. | |
dc.contributor.author | Kaal, S. | |
dc.contributor.author | Kasper, B. | |
dc.contributor.author | Kopeckova, K. | |
dc.contributor.author | Krakorova, D. A. | |
dc.contributor.author | Le Cesne, A. | |
dc.contributor.author | Lugowska, I. | |
dc.contributor.author | Merimsky, O. | |
dc.contributor.author | Montemurro, M. | |
dc.contributor.author | Pantaleo, M. A. | |
dc.contributor.author | Piana, R. | |
dc.contributor.author | Picci, P. | |
dc.contributor.author | Piperno-Neumann, S. | |
dc.contributor.author | Pousa, A. L. | |
dc.contributor.author | Reichardt, P. | |
dc.contributor.author | Robinson, M. H. | |
dc.contributor.author | Rutkowski, P. | |
dc.contributor.author | Safwat, A. A. | |
dc.contributor.author | Schoffski, P. | |
dc.contributor.author | Sleijfer, S. | |
dc.contributor.author | Stacchiotti, S. | |
dc.contributor.author | Hall, K. Sundby | |
dc.contributor.author | Unk, M. | |
dc.contributor.author | Van Coevorden, F. | |
dc.contributor.author | Van der Graaf, W. | |
dc.contributor.author | Whelan, J. | |
dc.contributor.author | Wardelmann, E. | |
dc.contributor.author | Zaikova, O. | |
dc.contributor.author | Blay, J. Y. | |
dc.contributor.author | ESMO Guidelines Comm EURACAN | |
dc.contributor.authoraffiliation | [Casali, P. G.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy | |
dc.contributor.authoraffiliation | [Frezza, A. M.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy | |
dc.contributor.authoraffiliation | [Gronchi, A.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy | |
dc.contributor.authoraffiliation | [Casali, P. G.] Univ Milan, Milan, Italy | |
dc.contributor.authoraffiliation | [Frezza, A. M.] Univ Milan, Milan, Italy | |
dc.contributor.authoraffiliation | [Gronchi, A.] Univ Milan, Milan, Italy | |
dc.contributor.authoraffiliation | [Abecassis, N.] EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Lisbon, Portugal | |
dc.contributor.authoraffiliation | [Bauer, S.] Univ Hosp Essen, Essen, Germany | |
dc.contributor.authoraffiliation | [Biagini, R.] Regina Elena Inst Canc Res, IFO, Musculoskeletal Tissue Bank, Dept Oncol Orthoped, Rome, Italy | |
dc.contributor.authoraffiliation | [Bielack, S.] Olga Hosp, Klinikum Stuttgart, Stuttgart, Germany | |
dc.contributor.authoraffiliation | [Bonvalot, S.] Inst Curie, Paris, France | |
dc.contributor.authoraffiliation | [Piperno-Neumann, S.] Inst Curie, Paris, France | |
dc.contributor.authoraffiliation | [Boukovinas, I.] NORDIX, Athens, Greece | |
dc.contributor.authoraffiliation | [Bovee, J. V. M. G.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands | |
dc.contributor.authoraffiliation | [Brodowicz, T.] Med Univ Wien, Vienna Gen Hosp AKH, Vienna, Austria | |
dc.contributor.authoraffiliation | [Broto, J. M.] Hosp Univ Virgen Rocio, CIBERONC, Seville, Spain | |
dc.contributor.authoraffiliation | [De Alava, E.] Hosp Univ Virgen Rocio, CIBERONC, Seville, Spain | |
dc.contributor.authoraffiliation | [Buonadonna, A.] Ctr Riferimento Oncol Aviano, Aviano, Italy | |
dc.contributor.authoraffiliation | [Dei Tos, A. P.] Osped Reg Treviso S Maria Ca Foncello, Treviso, Italy | |
dc.contributor.authoraffiliation | [Del Muro, X. G.] HUB, ICO Hosp, Integrated Unit, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Dileo, P.] Univ Coll London Hosp, Sarcoma Unit, London, England | |
dc.contributor.authoraffiliation | [Eriksson, M.] Skane Univ Hosp Lund, Lund, Sweden | |
dc.contributor.authoraffiliation | [Fedenko, A.] NN Blokhin Russian Canc Res Ctr, Moscow, Russia | |
dc.contributor.authoraffiliation | [Ferraresi, V.] Inst Sci Hosp Care, Regina Elena Natl Canc Inst, IRCCS, Rome, Italy | |
dc.contributor.authoraffiliation | [Ferrari, A.] Fdn IRCCS Ist Nazl Tumori, Pediat Oncol Unit, Milan, Italy | |
dc.contributor.authoraffiliation | [Ferrari, S.] Ist Ortoped Rizzoli, Bologna, Italy | |
dc.contributor.authoraffiliation | [Picci, P.] Ist Ortoped Rizzoli, Bologna, Italy | |
dc.contributor.authoraffiliation | [Gasperoni, S.] Univ Careggi Firenze, Azienda Osped, Florence, Italy | |
dc.contributor.authoraffiliation | [Gelderblom, H.] Leiden Univ, Med Ctr, Dept Med Oncol, Leiden, Netherlands | |
dc.contributor.authoraffiliation | [Gil, T.] Inst Jules Bordet, Brussels, Belgium | |
dc.contributor.authoraffiliation | [Grignani, G.] IRCCS, FPO, Candiolo Canc Inst, Candiolo, Italy | |
dc.contributor.authoraffiliation | [Haas, R. L.] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands | |
dc.contributor.authoraffiliation | [Haas, R. L.] Leiden Univ, Med Ctr, Dept Radiotherapy, Leiden, Netherlands | |
dc.contributor.authoraffiliation | [Hannu, A.] Turku Univ Hosp, Turun Yliopistollinen Keskussairaala, Turlu, Finland | |
dc.contributor.authoraffiliation | [Hassan, B.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England | |
dc.contributor.authoraffiliation | [Hohenberger, P.] Mannheim Univ, Med Ctr, Mannheim, Germany | |
dc.contributor.authoraffiliation | [Kasper, B.] Mannheim Univ, Med Ctr, Mannheim, Germany | |
dc.contributor.authoraffiliation | [Issels, R.] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 3, Munich, Germany | |
dc.contributor.authoraffiliation | [Joensuu, H.] Univ Helsinki, Cent Hosp, HUCH, Helsinki, Finland | |
dc.contributor.authoraffiliation | [Jones, R. L.] Royal Marsden Hosp, London, England | |
dc.contributor.authoraffiliation | [Van der Graaf, W.] Royal Marsden Hosp, London, England | |
dc.contributor.authoraffiliation | [Judson, I.] Inst Canc Res, London, England | |
dc.contributor.authoraffiliation | [Jutte, P.] Univ Med Ctr Groningen, Groningen, Netherlands | |
dc.contributor.authoraffiliation | [Kaal, S.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands | |
dc.contributor.authoraffiliation | [Kopeckova, K.] Univ Hosp Motol, Prague, Czech Republic | |
dc.contributor.authoraffiliation | [Krakorova, D. A.] Masaryk Mem Canc Inst, Brno, Czech Republic | |
dc.contributor.authoraffiliation | [Le Cesne, A.] Gustave Roussy Canc Campus, Villejuif, France | |
dc.contributor.authoraffiliation | [Lugowska, I.] Marie Sklodowska Curie Inst, Oncol Ctr, Warsaw, Poland | |
dc.contributor.authoraffiliation | [Rutkowski, P.] Marie Sklodowska Curie Inst, Oncol Ctr, Warsaw, Poland | |
dc.contributor.authoraffiliation | [Merimsky, O.] Tel Aviv Sourasky Med Ctr Ichilov, Tel Aviv, Israel | |
dc.contributor.authoraffiliation | [Montemurro, M.] Univ Hosp Lausanne, Med Oncol, Lausanne, Switzerland | |
dc.contributor.authoraffiliation | [Pantaleo, M. A.] Univ Bologna, Policlin S Orsola Malpighi, Azienda Osped, Bologna, Italy | |
dc.contributor.authoraffiliation | [Piana, R.] Univ Cita Salute & Sci Torino, Azienda Osped, Turin, Italy | |
dc.contributor.authoraffiliation | [Pousa, A. L.] Hosp Santa Creu & Sant Pau, Fundacio Gestio Sanitaria, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Reichardt, P.] Helios Klinikum Berlin Buch, Berlin, Germany | |
dc.contributor.authoraffiliation | [Robinson, M. H.] Weston Pk Hosp NHS Trust, Dept Clin Oncol, YCRC, Sheffield, S Yorkshire, England | |
dc.contributor.authoraffiliation | [Safwat, A. A.] Aarhus Univ Hosp, Aarhus, Denmark | |
dc.contributor.authoraffiliation | [Schoffski, P.] Leuven Canc Inst, Leuven, Belgium | |
dc.contributor.authoraffiliation | [Sleijfer, S.] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands | |
dc.contributor.authoraffiliation | [Stacchiotti, S.] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Milan, Italy | |
dc.contributor.authoraffiliation | [Hall, K. Sundby] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway | |
dc.contributor.authoraffiliation | [Unk, M.] Inst Oncol Ljubljana, Ljubljana, Slovenia | |
dc.contributor.authoraffiliation | [Van Coevorden, F.] Netherlands Canc Inst Antoni van Leeuwenhoek, Amsterdam, Netherlands | |
dc.contributor.authoraffiliation | [Whelan, J.] Univ Coll Hosp, London, England | |
dc.contributor.authoraffiliation | [Wardelmann, E.] Univ Klinikum Munster, Gerhard Domagk Inst Pathol, Munster, Germany | |
dc.contributor.authoraffiliation | [Zaikova, O.] Norwegian Radium Hosp, Oslo Univ Hosp, Oslo, Norway | |
dc.contributor.authoraffiliation | [Blay, J. Y.] Ctr Leon Bernard, Lyon, France | |
dc.contributor.authoraffiliation | [Blay, J. Y.] UCBL1, Lyon, France | |
dc.contributor.funder | Amgen Dompe | |
dc.contributor.funder | AROG Bayer | |
dc.contributor.funder | Blueprint Medicines | |
dc.contributor.funder | Eli Lilly | |
dc.contributor.funder | Daiichi Sankyo Pharma | |
dc.contributor.funder | Epizyme | |
dc.contributor.funder | GlaxoSmithKline | |
dc.contributor.funder | Novartis | |
dc.contributor.funder | Pfizer | |
dc.contributor.funder | PharmaMar | |
dc.contributor.funder | Incyte | |
dc.contributor.funder | Lilly | |
dc.contributor.funder | Bayer | |
dc.contributor.funder | Janssen-Cilag | |
dc.contributor.funder | Eisai | |
dc.contributor.funder | Loxo Oncology | |
dc.contributor.funder | Nanobiotix | |
dc.contributor.funder | Bristol-Myers Squibb | |
dc.contributor.funder | Merck Sharp Dohme | |
dc.contributor.funder | Roche | |
dc.contributor.funder | Amgen | |
dc.contributor.funder | EuroSarc | |
dc.contributor.funder | CoBioRes | |
dc.contributor.funder | Exelixis | |
dc.contributor.funder | Plexxikon | |
dc.contributor.funder | Sixth Element Capital | |
dc.contributor.funder | Adaptaimmune | |
dc.contributor.funder | Amcure | |
dc.contributor.funder | AstraZeneca | |
dc.contributor.funder | Boehringer Ingelheim | |
dc.contributor.funder | Cristal Therapeutics | |
dc.contributor.funder | Daichii Sankyo Pharma | |
dc.contributor.funder | Genzyme | |
dc.contributor.funder | Ipsen | |
dc.contributor.funder | Medpace | |
dc.contributor.funder | Nektar | |
dc.contributor.funder | Philogen | |
dc.contributor.funder | Piqur Therapeutics | |
dc.contributor.funder | Swedish Orphan Biovitrium | |
dc.contributor.funder | Advenchen | |
dc.contributor.funder | Epizyme Inc. | |
dc.contributor.funder | PharmarMar | |
dc.contributor.funder | Novartis Oncology | |
dc.contributor.funder | Milestone | |
dc.contributor.funder | Menarini | |
dc.date.accessioned | 2023-02-12T02:21:21Z | |
dc.date.available | 2023-02-12T02:21:21Z | |
dc.date.issued | 2018-10-01 | |
dc.identifier.doi | 10.1093/annonc/mdy095 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753419316916/pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/18935 | |
dc.identifier.wosID | 448047900006 | |
dc.issue.number | 4 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 68-78 | |
dc.publisher | Oxford univ press | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Phase-ii trial | |
dc.subject | Neoadjuvant/adjuvant imatinib mesylate | |
dc.subject | Adjuvant imatinib | |
dc.subject | Carney-stratakis | |
dc.subject | Dose imatinib | |
dc.subject | Gist | |
dc.subject | Mutations | |
dc.subject | Surgery | |
dc.subject | Progression | |
dc.subject | Recurrence | |
dc.title | Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 29 | |
dc.wostype | Article | |
dspace.entity.type | Publication |